Historique
Document multimédia
European Drug Emergencies Network (Euro-DEN Plus): data and analysis
Auteur(s) :
EUDA (European Union Drugs Agency)
Année
2025
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
Domaine :
Alcool / Alcohol ; Autres substances / Other substances ; Drogues illicites / Illicit drugs
Thésaurus géographique
EUROPE
Thésaurus mots-clés
PRODUIT ILLICITE
;
MEDICAMENTS
;
ALCOOL
;
URGENCE
;
ADMISSION
;
TOXICITE
;
POLYCONSOMMATION
;
MESUSAGE
;
HOPITAL
Résumé :
On this page you can explore data from the hospitals participating in the European Drug Emergencies Network (Euro-DEN - Euro-DEN Plus) project.
Since 2013, the project has been collecting data on acute drug toxicity presentations in an expanding network of sentinel hospitals across Europe and beyond. Euro-DEN Plus aims to provide detailed information on the nature and extent of acute harm associated with the use of illicit drugs, such as cannabis, cocaine, heroin and other opioids, amphetamines, and new psychoactive substances, used alone or in combination with other drugs, prescription medicines, over the counter medicines and alcohol.
Data from all centres can be explored, by year and selected substances, through our interactive data explorer. In addition, we present a detailed analysis of the 2024 data available from the centres in 19 countries in the European Union and Norway. [Introduction]
Since 2013, the project has been collecting data on acute drug toxicity presentations in an expanding network of sentinel hospitals across Europe and beyond. Euro-DEN Plus aims to provide detailed information on the nature and extent of acute harm associated with the use of illicit drugs, such as cannabis, cocaine, heroin and other opioids, amphetamines, and new psychoactive substances, used alone or in combination with other drugs, prescription medicines, over the counter medicines and alcohol.
Data from all centres can be explored, by year and selected substances, through our interactive data explorer. In addition, we present a detailed analysis of the 2024 data available from the centres in 19 countries in the European Union and Norway. [Introduction]